Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Cell & Gene Therapy Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Application (Cardiology, CNS, Dermatology) - Global Forecast 2024-2030
... USD 6.67 billion in 2023 and expected to reach USD 7.53 billion in 2024, at a CAGR 13.36% to reach USD 16.05 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Nutrigenomics Market by Product (Reagents & Kits, Services), Application (Cancer, Cardiovascular Diseases, Obesity) - Global Forecast 2024-2030
... million in 2024, at a CAGR 17.53% to reach USD 1,887.63 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Nutrigenomics Market. It offers a comprehensive assessment of vendors, ... Read More
-
Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Global Forecast 2024-2030
... was estimated at USD 1.16 billion in 2023 and expected to reach USD 1.27 billion in 2024, at a CAGR 9.63% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Global Forecast 2024-2030
... estimated at USD 3.78 billion in 2023 and expected to reach USD 4.11 billion in 2024, at a CAGR 8.93% to reach USD 6.88 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Atherectomy Devices Market by Product (Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices), Application (Cardiovascular, Neurovascular, Peripheral Vascular), End User - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 1,039.43 million in 2024, at a CAGR 8.28% to reach USD 1,692.53 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Lymphedema Diagnostics Market by Technology (Bioimpedance Analysis, Computed Tomography, Lymphoscintigraphy), Disease (Cancer, Cardiovascular Disease, Inflammatory Diseases), End User - Global Forecast 2024-2030
... and expected to reach USD 35.46 million in 2024, at a CAGR 9.26% to reach USD 60.40 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Lymphedema Diagnostics Market. ... Read More
-
Cardiac Biomarkers Testing Global Market Report 2024
... Infarction; Atherosclerosis3) By End-User: Hospitals; Specialty ClinicsCovering: Abbott Laboratories; Bio-Rad Laboratories Inc.; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG Cardiac Biomarkers Testing Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Drug Formulation Global Market Report 2024
... Cancer; Respiratory Diseases4) By End-User: Big Pharma; Small And Medium Pharma; Biotech Companies Covering: AstraZeneca PLC; The Bristol-Myers Squibb Company; Eli Lilly and Company; Gilead Sciences Inc.; Merck & Co. Inc. Drug Formulation Global Market ... Read More
-
Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User - Global Forecast to 2028
... management market is projected to reach USD 654 million by 2028 from USD 343 million in 2023, at a CAGR of 13.8% from 2023 to 2028. The growth of the market is driven by a ... Read More
-
Global Heart Transplantation Therapeutics Market 2024-2028
... heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Gene Therapy On Cardiovascular Disease Market Research Report 2024(Status and Outlook)
... doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential ... Read More
-
Cardiopulmonary Exercise Testing Market Research Report Forecast till 2030
... and aspiratory hypertension among others across the globe is driving the development of the cardiopulmonary exercise testing market. Cardiopulmonary exercise testing gives important symptomatic data and assists in deciding with practicing limit and utilitarian limits ... Read More
-
Stroke Post Processing Software Market Research Report Forecast till 2030
... ready for significant development driven by expanding stroke rates, high level imaging innovations, developing accentuation on convenient and precise analysis. As medical services suppliers focus on productive examination of clinical pictures for worked on quiet ... Read More
-
Percutaneous Coronary Intervention Market Research Report Forecast till 2032
... vigorous growth driven by mechanical progressions, expanding commonness of cardiovascular infections, and a rising maturing populace. With an emphasis on insignificantly obtrusive techniques and creative stent innovations, the market is ready to observe supported extension, ... Read More
-
Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032 Including: 1) By Offering: Software; Services 2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring 3) By Application: Oncology; Neurological Disease And Condition; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease 4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research Organizations Covering: Saama Technologies Inc.; Trials.Ai; Innoplexus AG; Deep 6 AI In; Unlearn.AI, Inc.
... Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research OrganizationsCovering: Saama Technologies Inc.; Trials.Ai; Innoplexus AG; Deep 6 AI In; Unlearn.AI, Inc. Artificial Intelligence (AI) In Clinical Trials ... Read More
-
2024 Global Forecast for Cardiac Biomarkers (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
2024 Global Anticoagulant Reversal Industry (2030 Outlook)
... reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total value of ... Read More
-
Heart Failure POC & LOC Devices Market Size, Share, and Analysis, By Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Technology (Microfluidics, Array-Based Systems, Others), By End User (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory) and Regional Forecasts, 2022-2032
... Facilities, Laboratory) and Regional Forecasts, 2022-2032 PRODUCT OVERVIEW Heart Failure POC & LOC Devices Market size was USD 66.11 million in 2021 and projected to grow from USD 89.6 million in 2023 to USD 360.1 ... Read More
-
2024 Global Forecast for Congestive Heart Failure (Chf) Treatment Devices (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
Acute Ischemic Stroke (AIS) - Competitive Landscape
... 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for AIS. There are only eight marketed drugs for AIS, with alteplase being marketed by various companies under various brand names and in multiple geographies. ... Read More
-
Companion Diagnostics Market, By Technology Type (Real Time-Polymerase Chain Reactions (PCR), Gene Sequencing, Fluorescence in situ Hybridization, and Others) By Application (Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Diseases and Others), By End User (Hospitals, Research Laboratories, Biopharmaceutical companies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Laboratories, Biopharmaceutical companies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) Companion diagnostics are medical devices that are used to detect specific biomarkers or genes in patients that ... Read More
-
Patient Engagement Solutions Market by Component (Hardware (Tablet)), Software (Integrated), Therapy (CVD, Diabetes), Functionality (Education, Scheduling), User (Provider, Payer (Public)), Unmet Need, Investment, Buying Criteria - Global Forecast to 2028
... is projected to reach USD 41.8 billion by 2028 from USD 22.5 billion in 2023, at a CAGR of 13.2% during the forecast period. Factors such as the growing demand for patient engagement solutions and ... Read More
-
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) - Global Forecast to 2028
... is projected to reach USD 615 million by 2028 from USD 286 million in 2023, at a CAGR of 16.5% during the forecast period. Key market players are focusing on developing new stem cell therapies ... Read More
-
2024 Global Forecast for Anticoagulant Reversal (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Fabricated Metal Product Manufacturing industry. The product or service category is within the NAICS Fabricated Metal Product Manufacturing industry. The global market is expected to ... Read More
-
Enzyme Inhibitor Global Market Report 2024
... Gastrointestinal Disorders; Arthritis; Inflammatory Diseases3) By Application: Chemotherapy; Antibiotics; Pesticides; Cardiovascular Treatments4) By End User: Pharmaceutical; Biotechnology; Food and BeverageCovering: Abbott Laboratories; Amgen Inc.; AstraZeneca plc; Bayer AG; F. Hoffmann-La Roche AG Enzyme Inhibitor Global ... Read More
Research Assistance
